Immuneering Corporation Class A Common Stock

IMRXNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
4.64 USD
↘ 0.14 (2.93%)AT CLOSE (11:59 AM EDT)
4.77
↗ 0.13 (2.78%)
POST MARKET (AS OF 07:49 PM EDT)
Post Market
AS OF 07:49 PM EDT
4.77
↗ 0.13 (2.78%)
🔴Market: CLOSED

Immuneering Corporation Class A Common Stock (IMRX) trades at $4.63 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, IMRX appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jul 17, 2026.

Open?$4.72
High?$4.89
Low?$4.62
Prev. Close?$4.78
Volume?1.4M
Avg. Volume?1.5M
VWAP?$4.72
Rel. Volume?0.98x
Bid / Ask
Bid?$3.95 × 100
Ask?$5.59 × 100
Spread?$1.64
Midpoint?$4.77
Valuation & Ratios
Market Cap?309.3M
Shares Out?64.7M
Float?55.9M
Float %?86.5%
P/E Ratio?N/A
P/B Ratio?1.50
EPS?-$0.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyAI & Machine Learning›AI-Powered Analytics & Decision Systems
Employees
55
Market Cap
309.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.immuneering.com
Listed
2021-07-30
Address
245 MAIN STREET, SECOND FLOOR
CAMBRIDGE, MA 02142
Phone: 617-500-8080
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
77
Short Sent.?
31
Piotroski F-Score?0/9Weak
Altman Z-Score?20.43Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?26.87%Squeeze Risk
Short Interest?15.0M
Days to Cover?7.6
Free Float55.9M
Avg Daily Volume2.0M
Settlement Date2026-06-30
Financial Health
Current Ratio?32.45Strong
Quick Ratio?32.45Strong
Cash Ratio?9.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
87
1.50CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-26.4%WEAK▾
ROA?
S&P
3
-25.3%WEAK▾
Cash Flow & Enterprise
FCF?$-49910612
Enterprise Value?$261.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist